Contribution: Eureka/Eurostar
Nutrasource Pharmaceutical and Nutraceutical Services Inc.
$465,000.00
EUREKA Network Project E!12216 / NDI: Rapid Omega-3 Fatty Acid Diagnostic Test
FY 2018-19 · 2018-06-01
Summary
The purpose of this project, EUREKA Network Project E!12216, is to develop the world’s first rapid, point-of-care omega-3 diagnostic device. This device will quickly tell users whether they have sufficient levels of the omega-3 fatty acid docosahexaenoic acid (DHA) in their blood. Project to be executed by Canada based Nutrasource Diagnostics Inc. and their Austria based partner SAICO Biosystems.
Department
Program
Eureka/Eurostar
Location
Guelph|Guelph, Ontario, Canada
Recipient Type
For-profit organization
Business Number
865125264
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2018-06-01 | 2018-19 | $465,000.00 |
| 4 | 2018-06-01 | 2018-19 | $465,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 272 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 272 jours.
Agreement End Date
2021-02-28
Agreement Number
908598
Agreement Start Date
2018-06-01
Agreement Title
EUREKA Network Project E!12216 / NDI: Rapid Omega-3 Fatty Acid Diagnostic Test
Agreement Title (French)
Projet de réseau d’Eureka E!12216 / NDI : test diagnostique rapide d'acide gras oméga-3
Agreement Type
Contribution
Agreement Value
$465,000.00
Amendment Date
2020-05-15
Amendment Number
4
Coverage
EUREKA is a leading facilitator of innovation, providing a proven platform for international R&D&I cooperation. | EUREKA est un facilitateur de premier plan en innovation, fournissant une plate-forme reconnu pour la coopération internationale en R & D & I.
Description
The purpose of this project, EUREKA Network Project E!12216, is to develop the world’s first rapid, point-of-care omega-3 diagnostic device. This device will quickly tell users whether they have sufficient levels of the omega-3 fatty acid docosahexaenoic acid (DHA) in their blood. Project to be executed by Canada based Nutrasource Diagnostics Inc. and their Austria based partner SAICO Biosystems.
Description (French)
Le but de ce projet, EUREKA Network Project E!12216, consiste à développer le premier dispositif de diagnostic oméga-3 à point de service mondial rapide. Ce dispositif pourra rapidement aviser les utilisateurs s’ils ont suffisamment de niveaux d’acide gras oméga-3 docosahexanoïque (DHA) dans leur sang. Le projet sera exécuté par l'entreprise au Canada, Nutrasource Diagnostics Inc. et son partenaire en Autriche, SAICO Biosystems.
Expected Results
Eureka promotes and supports market-oriented international R&D&I project generation, and facilitates access to financing for companies involved in its projects. EUREKA’s strength lies in its well-established international network, connecting 41 full member countries from Europe and 4 associated member countries.
Expected Results (French)
Eureka promouvoit et soutient la génération de projets internationaux de R & D & I axés sur le marché et facilite l'accès au financement pour les entreprises impliquées dans ses projets. La force d'EUREKA réside dans son réseau international bien établi, qui relie 41 pays membres d'Europe et 4 pays membres associés.
Federal Riding
Guelph
Federal Riding (French)
Guelph
Federal Riding Number
35032
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Eureka/Eurostar
Program Name (French)
Eureka/Eurostar
Program Purpose
Eureka promotes and supports market-oriented international R&D&I project generation, and facilitates access to financing for companies involved in its projects. EUREKA’s strength lies in its well-established international network, connecting 41 full member countries from Europe and 4 associated member countries.
Program Purpose (French)
Eureka promouvoit et soutient la génération de projets internationaux de R & D & I axés sur le marché et facilite l'accès au financement pour les entreprises impliquées dans ses projets. La force d'EUREKA réside dans son réseau international bien établi, qui relie 41 pays membres d'Europe et 4 pays membres associés.
Recipient Business Number
865125264
Recipient City
Guelph|Guelph
Recipient Country
CA
Recipient Legal Name
Nutrasource Pharmaceutical and Nutraceutical Services Inc.
Recipient Operating Name
NDI
Recipient Postal Code
N1G 0B4
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2018-2019-Q1-908598
